3 days ago · Molecular Assemblies proprietary Fully Enzymatic Synthesis TM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business. SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual ...

“Molecular Assemblies is the original leader in enzymatic oligo synthesis, with strong foundational IP. Their team has made great strides in designing and developing an enzymatic DNA synthesis platform with exciting technical advantages over traditional chemical synthesis,” said Trey Martin, CEO of Maravai LifeSciences.

3 days ago · About Molecular Assemblies Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products.

3 days ago · “Molecular Assemblies is the original leader in enzymatic oligo synthesis, with strong foundational IP. Their team has made great strides in designing and developing an enzymatic DNA synthesis platform with exciting technical advantages over traditional chemical synthesis,” said Trey Martin, CEO of Maravai LifeSciences.

3 days ago · Maravai LifeSciences acquires cutting-edge enzymatic synthesis technology from Molecular Assemblies, ... About Maravai. Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in ...

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies. ... Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe. Extraordinary science. Everyday miracles.

3 days ago · Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property and relevant assets from Molecular Assemblies (MAI).

3 days ago · Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today its acquisition of intellectual property and relevant assets from Molecular Assemblies (MAI). The acquisition will expand Maravai and TriLink BioTechnologies' ability to enable customers to develop next-generation mRNA and CRISPR nucleic acid ...

Maravai LifeSciences (NASDAQ:MRVI) announced on Tuesday the acquisition of intellectual property and relevant assets from Molecular Assemblies. The acquisition will expand Maravai and TriLink ...

Maravai LifeSciences Acquires Assets and Intellectual Property from Molecular Assemblies